MyFinsight
Home
About
Contact
aqst: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, AQST has $163,559K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
163,559
93,698
Total stockholders deficit
-4,109
-72,590
Total liabilities and stockholders deficit
163,559
93,698
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$2,925K
Inventories
$7,884K
Trade and other
receivables, net
$11,801K
Cash and cash
equivalents
$129,063K
Other non-current
assets
$3,199K
Right-of-use assets, net
$4,769K
Property and equipment,
net
$3,918K
Total current assets
$151,673K
Total assets
$163,559K
Accumulated deficit
-$415,138K
Total liabilities and
stockholders deficit
$163,559K
Total stockholders
deficit
-$4,109K
Additional paid-in capital
$410,908K
Common stock, 0.001 par
value. authorized...
$121K
Total liabilities
$167,668K
Other non-current
liabilities
$2,058K
Deferred revenue, net of
current portion
$19,663K
Lease liabilities
$4,508K
Liability related to the
sale of future...
$61,977K
Royalty obligations,
net
$23,948K
Notes payable, net
$29,940K
Total current
liabilities
$25,574K
Loans payable,
current
$6,327K
Royalty obligations,
current
$561K
Liability related to the
sale of future...
$1,000K
Deferred revenue,
current
$1,092K
Lease liabilities,
current
$601K
Accrued expenses
$5,128K
Accounts payable
$10,865K
Subscribe for Financial Insights
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)